The policy covers measures and procedures for approving transactions between the company, its subsidiaries and associated companies and persons who may have a conflict of interest, as well as the outlook for such transactions in the future. Transactions must follow normal commercial terms at fair market prices, and the Audit Committee gives its opinion on the necessity and pricing of each transaction.
Where the Audit Committee lacks the expertise to assess a transaction, an independent expert or the company's auditor provides an opinion. Persons with an interest in a transaction may not vote on its approval, and connected transactions are disclosed as required.